Jekunen AP - Search Results

1

The effect of three dimensional activity distribution on the dose planning of radioimmunotherapy for patients with advanced intraperitoneal pseudomyxoma.

Laitinen JO, Kairemo KJ, Jekunen AP, Korppi-Tommola T, Tenhunen M. Laitinen JO, et al. Among authors: jekunen ap. Cancer. 1997 Dec 15;80(12 Suppl):2545-52. doi: 10.1002/(sici)1097-0142(19971215)80:12+<2545::aid-cncr29>3.3.co;2-t. Cancer. 1997. PMID: 9406708

2

Oligoradionuclidetherapy using radiolabelled antisense oligodeoxynucleotide phosphorothioates.

Kairemo KJ, Tenhunen M, Jekunen AP. Kairemo KJ, et al. Among authors: jekunen ap. Anticancer Drug Des. 1996 Sep;11(6):439-49. Anticancer Drug Des. 1996. PMID: 8836109

3

Inhibition of malignant angiogenesis.

Jekunen AP, Kairemo KJ. Jekunen AP, et al. Cancer Treat Rev. 1997 Jul;23(4):263-86. doi: 10.1016/s0305-7372(97)90014-1. Cancer Treat Rev. 1997. PMID: 9377596 Review. No abstract available.

4

Gene therapy using antisense oligodeoxynucleotides labeled with Auger-emitting radionuclides.

Kairemo KJ, Tenhunen M, Jekunen AP. Kairemo KJ, et al. Among authors: jekunen ap. Cancer Gene Ther. 1998 Nov-Dec;5(6):408-12. Cancer Gene Ther. 1998. PMID: 9917096

5

The use of TL detectors in dosimetry of systemic radiation therapy.

Aschan AC, Toivonen MJ, Lampinen JS, Tenhunen M, Kairemo KJ, Korppi-Tommola ET, Jekunen AP, Sipilä P, Savolainen SE. Aschan AC, et al. Among authors: jekunen ap. Acta Oncol. 1999;38(2):189-96. doi: 10.1080/028418699431609. Acta Oncol. 1999. PMID: 10227440

6

Detection of pseudomyxoma peritonei by radioimmunohistochemistry and radioimmunoscintigraphy.

Kairemo KJ, Jekunen AP, Bondestam S, Korppi-Tommola ET, Savolainen S, Paavonen T. Kairemo KJ, et al. Among authors: jekunen ap. Cancer Biother Radiopharm. 1996 Oct;11(5):325-34. doi: 10.1089/cbr.1996.11.325. Cancer Biother Radiopharm. 1996. PMID: 10851513

7

Dosimetry of radionuclide therapy using radiophosphonated antisense oligodeoxynucleotide phosphorothioates based on animal pharmacokinetic and tissue distribution data.

Kairemo KJ, Tenhunen M, Jekunen AP. Kairemo KJ, et al. Among authors: jekunen ap. Antisense Nucleic Acid Drug Dev. 1996 Fall;6(3):215-20. doi: 10.1089/oli.1.1996.6.215. Antisense Nucleic Acid Drug Dev. 1996. PMID: 8915506

8

Double-tracer dosimetry of organs in assessment of bone marrow involvement by two monoclonal antibodies.

Korppi-Tommola ET, Kairemo KJ, Jekunen AP, Niskanen EO, Savolainen SE. Korppi-Tommola ET, et al. Among authors: jekunen ap. Acta Oncol. 1996;35(3):357-65. doi: 10.3109/02841869609101652. Acta Oncol. 1996. PMID: 8679267

9

Imaging of Hand-Schüller-Christian syndrome by a monoclonal antibody.

Jekunen AP, Kairemo KJ, Paavonen T. Jekunen AP, et al. Clin Nucl Med. 1997 Nov;22(11):771-4. doi: 10.1097/00003072-199711000-00009. Clin Nucl Med. 1997. PMID: 9363388

10

Inhibition of angiogenesis at endothelial cell level.

Jekunen A, Kairemo K. Jekunen A, et al. Microsc Res Tech. 2003 Jan 1;60(1):85-97. doi: 10.1002/jemt.10247. Microsc Res Tech. 2003. PMID: 12500265 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

97 results

Search Page

Filters